BCK Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Hold
200
– – 0.11% 26
2026
Q2
$240K Buy
+200
New +$204K 0.12% 25
2026
Q1
– Sell
-214
Closed -$230K – 27
2025
Q4
$230K Buy
+214
New +$205K 0.12% 25
2025
Q2
– Sell
-244
Closed -$202K – 28
2025
Q1
$202K Buy
+244
New +$203K 0.13% 25
2024
Q4
– Sell
-284
Closed -$252K – 29
2024
Q3
$252K Hold
284
– – 0.12% 28
2024
Q2
$257K Buy
+284
New +$227K 0.13% 29

Other funds holding LLY

BCK Partners's LLY Position: Q3 2026 in Review

BCK Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 200 shares worth $231K. The position accounts for 0.11% of the portfolio, ranked #26.

BCK Partners first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. The position peaked at $257K in Q2 2024. 2,227 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BCK Partners held 200 shares of Eli Lilly worth $231K as of Q3 2026.
  • BCK Partners left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.11% of BCK Partners's portfolio in Q3 2026, its #26 holding.
  • BCK Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • BCK Partners's Eli Lilly position peaked at $257K in Q2 2024.
  • 2,227 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BCK Partners's 13F filing for Q3 2026, filed 23 Oct 2026.